Liquid biopsy in colorectal cancer: redefining surgical decision-making.
Liquid biopsy tests that detect tumor material in blood offer a simpler, less invasive way to monitor cancer progression.
This PubMed record reports liquid biopsy (LB) has rapidly emerged as a minimally invasive approach to detecting tumor-derived material in the bloodstream, including circulating tumor DNA (ctDNA), circulating tumor cells, and extracellular vesicles. The study was classified as narrative review and is relevant to early detection.
What the study was
- Study design
- Narrative review
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Updates in surgery
Why it surfaced
Conservative triage based on the PubMed abstract, narrative review, clinical relevance, and unmet-need signals.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.